Chromatogen Analytical Solutions (Opc) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-12-2024
- Paid Up Capital ₹ 5.00 M
as on 30-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.11 Cr
as on 30-12-2024
- Satisfied Charges ₹ 7.07 M
as on 30-12-2024
- Revenue 22.93%
(FY 2021)
- Profit 14.67%
(FY 2021)
- Ebitda 16.11%
(FY 2021)
- Net Worth 165.18%
(FY 2021)
- Total Assets 187.32%
(FY 2021)
About Chromatogen Analytical Solutions (Opc)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.11 Cr. The company has closed loans amounting to ₹7.07 M, as per Ministry of Corporate Affairs (MCA) records.
Manasa Gantagowdanahalli serves as a director at the Company.
- CIN/LLPIN
U24230KA2017OPC105419
- Company No.
105419
- Incorporation Date
09 Aug 2017
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chromatogen Analytical Solutions (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manasa Gantagowdanahalli  | Director | 09-Aug-2017 | Current |
Financial Performance of Chromatogen Analytical Solutions (Opc).
Chromatogen Analytical Solutions (Opc) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 22.93% increase. The company also saw a substantial improvement in profitability, with a 14.67% increase in profit. The company's net worth Soared by an impressive increase of 165.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chromatogen Analytical Solutions (Opc)?
In 2021, Chromatogen Analytical Solutions (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 01 Sep 2023 | ₹2.88 M | Open |
Canara Bank Creation Date: 08 May 2023 | ₹3.54 M | Open |
Canara Bank Creation Date: 18 Oct 2022 | ₹2.47 Cr | Open |
How Many Employees Work at Chromatogen Analytical Solutions (Opc)?
Unlock and access historical data on people associated with Chromatogen Analytical Solutions (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chromatogen Analytical Solutions (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chromatogen Analytical Solutions (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
